David D. Chang

Insider Reports History

Entity
Individual
Location
C/O Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco, CA
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David D. Chang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. President and CEO, Director Common Stock 4.81M $13.9M $2.90 May 16, 2024 Direct
Allogene Therapeutics, Inc. President and CEO, Director Common Stock 856K $2.48M $2.90 May 16, 2024 Indirect
Allogene Therapeutics, Inc. President and CEO, Director Stock Option (Right to buy) 1.12M Jan 25, 2024 Direct

Insider Reports Filed by David D. Chang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. May 16, 2024 1 $1M 4 May 20, 2024 President and CEO, Director
ALLO Allogene Therapeutics, Inc. Mar 14, 2024 1 -$231K 4 Mar 18, 2024 President and CEO, Director
ALLO Allogene Therapeutics, Inc. Jan 25, 2024 2 $0 4 Jan 31, 2024 President and CEO, Director
ALLO Allogene Therapeutics, Inc. Mar 22, 2023 2 $0 4 Mar 24, 2023 President and CEO, Director
ALLO Allogene Therapeutics, Inc. Mar 14, 2023 1 -$124K 4 Mar 16, 2023 President and CEO, Director
ALLO Allogene Therapeutics, Inc. Mar 23, 2022 1 $0 4 Mar 25, 2022 President and CEO, Director
ALLO Allogene Therapeutics, Inc. Mar 15, 2022 1 -$181K 4 Mar 17, 2022 President and CEO, Director
ALLO Allogene Therapeutics, Inc. May 24, 2021 2 $499K 4 May 26, 2021 President and CEO, Director